Centrexion Therapeutics Corporation
Latest round
- Series D
Last raised
- Jan 2018
Total raised
- $91M
Investors
- 7
About Centrexion Therapeutics Corporation
Founded in 2013, chaired by Jeffery B. Kindler as CEO and based in Massachusetts, the US, Centrexion Therapeutics Corporation, is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies for chronic pain.5 million from Lilly Asia Ventures, Exome Asset Management, and Solar Capital among others. As of 2021, the company employs over 20 employees. The company’s drug candidates include topical gel, joint or deeper tissue injection, spinal delivery, and oral therapies. Centrexion Therapeutics’ develops therapies that target the origin of the pain signal to relieve chronic pain. The firm makes use of big data analytics, translational science, and early-stage clinical trials to develop therapies for disease areas such as oncology. The company’s flagship product and the novel patented candidate, CNTX-4975, provides a non-opioid and non-addictive method to relieve chronic pain caused by osteoarthritis of the knee and includes neuropathic and inflammatory pain, which are associated with a wide variety of diseases. The company’s product candidate also includes CNTX-0290 for neuropathic, musculoskeletal and inflammatory pain, CNTX-6970 for inflammatory and osteoarthritis pain, CNTX-2022 for superficial pain and CNTX-6016 for diabetic neuropathic pain. The company plans on utilizing the investments acquired in 2020 to strengthen its ability to advance the existing drug candidate pipeline that extends from mid-stage development to large registrational clinical trials. Additionally, the firm plans to leverage its expertise by pursuing licensing opportunities for promising mid-stage assets across many target therapeutics areas. Centrexion Therapeutics plans on advancing the development of CNTX- 4975 through Phase 3 registration trials and its commercialization on priority.
Who invested in Centrexion Therapeutics Corporation
7 investors across 3 rounds
See all investors in Centrexion Therapeutics Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Centrexion Therapeutics Corporation
Who invested in Centrexion Therapeutics Corporation?
Centrexion Therapeutics Corporation has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Centrexion Therapeutics Corporation raised?
Centrexion Therapeutics Corporation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Centrexion Therapeutics Corporation last raise money?
Centrexion Therapeutics Corporation's most recent round on record is a Series D, in Jan 2018.
What does Centrexion Therapeutics Corporation do?
Founded in 2013, chaired by Jeffery B.
Where is Centrexion Therapeutics Corporation headquartered?
Centrexion Therapeutics Corporation is headquartered in Boston, US.
Which VCs invest in companies like Centrexion Therapeutics Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Centrexion Therapeutics Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Centrexion Therapeutics Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.